Clinical Trials Browser

Phase EARLY_PHASE1 × Interventional × daratumumab × Clear all

NCT04139304 2025-06-29

A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma

Phase EARLY_PHASE1 Recruiting

Plasmablastic Lymphoma

NCT07026604 2025-06-18

CCM-DS01

Phase EARLY_PHASE1 Not yet recruiting

Hemangioma, Cavernous, Central Nervous System

NCT03473730 2025-01-30

Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer

Phase EARLY_PHASE1 Completed

Carcinoma, Renal Cell, Urologic Neoplasms